L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia

NCT00125788 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Anemia
Thalassemia

Interventions

DRUG: L-glutamine
DRUG: Placebo

Sponsor

Emmaus Medical, Inc.

Collaborators

[object Object]